Vancouver, BC (November 28, 2013) –The Centre for Drug Research and Development (CDRD) and the Prevention of Organ Failure Centre (PROOF Centre), both inaugural Centres of Excellence for Commercialization and Research (CECRs) headquartered in Vancouver, are pleased to announce they …
Vancouver, BC and Seattle, WA (October 16, 2013) – The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and MRM Proteomics Inc. will use their biomarker expertise in collaboration with the Jain Foundation, Inc. to identify blood-based …
The Fall 2013 issue of The Marker is here to keep you abreast of the latest news from the PROOF Centre.
Vancouver, BC (September 25, 2013) –The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and HTG Molecular Diagnostics are collaborating to begin clinical validation of a biomarker blood test that will provide early indication of organ rejection …
Heart, lung and kidney diseases together are responsible for more than 40 per cent of deaths and $3.46 trillion in healthcare spending worldwide. Biotechnology Focus covers how the PROOF Centre is developing cost-effective blood tests for heart, lung and kidney …